Summary
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
History
NanoVibronix is an early-stage medical device company that has developed and is commercializing its proprietary and patent protected ultrasound-based platform technology called PainShield®. The technology has been developed to provide physicians and patients with a safe, effective and easy-to-use application for both therapeutics and diagnostics that can be applied in multiple clinical settings.
Mission
At NanoVibronix, our mission is to provide healthcare professionals with cost-effective, non-invasive solutions that effectively treat patients with a diverse range of chronic and acute conditions, using the latest high-tech, user-friendly devices.
Vision
We are dedicated to innovating and launching therapeutic and diagnostic products that will improve patient outcomes and the quality of care. By bringing the power of ultrasound technology to medical applications beyond its traditional scope, we have the potential to radically transform the healthcare landscape.
Key Team
Mr. Amir Rippel (VP of Marketing)
Mrs. Lindsey Harrison (VP of Sales)
Recognition and Awards
The PainShield technology has won multiple awards and recognition since its initial patent in 2008, including the Medical Design Excellence Award and the World Technology Award. NanoVibronix also won the Most Innovative Company Award at the Healthcare Technology Conference.
References
